Interestingly, we found that TBX2 is induced by the EMT-promoting cytokine TGFß, which is often excessively produced by invasive breast cancer cells and has been associated with metastatic tumor progression [35]. The gene discussed is TBX2; the disease is invasive breast carcinoma.